Blood Screening Market by Technology (Western Blot Assay, Reverse Polymerase Chain Reaction (RPCR), Enzyme-Linked Immunosorbent Assay (ELISA)), By Product Type (Instruments, Software and Services, Reagents & Kits).
Global Blood Screening Market was valued at USD 2.35 Billion in the year 2017. Global Blood Screening Market is further estimated to grow at a CAGR of 4.46% from 2018 to 2023.
North America region holds the highest market share in 2017 with APAC region is considered as the fastest growing market in the forecasted period. At a country level, the U.S is the biggest market in 2017 and it is projected to grow at a gradual pace in the coming years.
Grifols (Spain), Roche Diagnostics (Switzerland), bioMérieux (France), Abbott Laboratories (U.S.) are some of the key manufacturers in the Global Blood Screening Market with Roche Diagnostics holding the substantial market share. Better global reach, both at production and at an operational level is the main reason for holding this highest market share.
Growing research and development expenditures to address changing demand of consumers, new product launches in recent years are some of the key market drivers. Organic growth strategies adopted by most of the top manufacturers in recent years is also providing comprehensive market opportunities for the various stakeholder.
Boosting Demand for blood supply
Increased focus on the safety of blood
Lack of regulatory standards
Level of required financial investment & lack of technical expertise
Rising importance of diagnostics in improving healthcare quality
Development of emerging markets for NAT technology.
Supply of safe blood
Intense competition and reduced healthcare reimbursement
The NAT (Nucleic Acid Test) segment holds the top market share during the forecast period. The growth can be attributed to the increasing number of blood donations, rising incidence of infectious diseases, and increasing capacity to pay for NAT blood tests.
On the other hand, by users hospitals & clinical Laboratories is projected to grow at the highest CAGR of XXX during the year 2017-2023. Mainly because there is increasing demand for donated blood, raising awareness for the safety of blood, growing number of blood donations worldwide, and growth in government investments.
Key Benefits for Stakeholders
Blood screening Manufacturers, Distributors, and Retailers
Research and Consulting organization
Technology Standards Organizations, Forums, Alliances and Associations
Regulatory bodies, policy actors, and consumers.
By-products & Services
Software and Services
Reagents & Kits
Western Blot Assay
Reverse Polymerase Chain Reaction (RPCR)
Enzyme-Linked Immunosorbent Assay (ELISA)
Nucleic Acid Test (NAT)
Next-Generation Sequencing (NGS)
Key Market Players
- 1. Abbott Laboratories
- 2. Ortho Clinical Diagnostics, Inc.
- 3. Biomérieux SA
- 4. Grifols SA
- 5. F. Hoffmann-La Roche AG
- 6. Becton, Dickinson and Company
- 7. Qiagen Netherlands (includes Digene)
- 8. Bio-Rad Laboratories, Inc.
- 9. Agilent Technologies (Dako)
- 10. Trinity Biotech
Read Report Overview with Full TOC at goo.gl/F94xoM
Category: Market Research Publishers and RetailersCompany about: Genesis Market Insights (GMI), is a subsidiary of Genesis Management & Market Research Pvt.Ltd. (GMMR) having a strong experience both in primary and secondary market research serving small to large scale enterprises across the globe. Established in 1993, GMMR has become a recommended brand for Market Research for various international and MNC Corporations with its strong data foundation. With its exhaustive research capabilities, strong analytics services and in-house data validation tools, ...